ENDRA Life Sciences Inc. (NDRA) stock
NDRANasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$4.04+0.12 (+2.93%)
Close on Nov 18, 2026Market cap $6.05MP/E –Yield –
ENDRA Life Sciences total assets
Total assets on the balance sheet at the end of each period.
ENDRA Life Sciences's total assets was $7.94M at Jun 30, 2026. For fiscal 2025 it was $3.85M, down 13.4% from the year before. The highest annual figure on record is $12.87M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.85M | -13.4% |
| FY2024 | Dec 31, 2024 | $4.45M | -34.1% |
| FY2023 | Dec 31, 2023 | $6.75M | -27.2% |
| FY2022 | Dec 31, 2022 | $9.27M | -28.0% |
| FY2021 | Dec 31, 2021 | $12.87M | +46.9% |
| FY2020 | Dec 31, 2020 | $8.76M | +22.1% |
| FY2019 | Dec 31, 2019 | $7.18M | -0.6% |
| FY2018 | Dec 31, 2018 | $7.22M | +17.9% |
| FY2017 | Dec 31, 2017 | $6.12M | +1147.8% |
| FY2016 | Dec 31, 2016 | $490.76K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $7.94M | +182.9% |
| Q1 FY2026 | Mar 31, 2026 | $3.44M | +8.4% |
| Q4 FY2025 | Dec 31, 2025 | $3.85M | -13.4% |
| Q3 FY2025 | Sep 30, 2025 | $1.96M | -76.6% |
| Q2 FY2025 | Jun 30, 2025 | $2.81M | -73.1% |
| Q1 FY2025 | Mar 31, 2025 | $3.17M | -37.3% |
| Q4 FY2024 | Dec 31, 2024 | $4.45M | -34.1% |
| Q3 FY2024 | Sep 30, 2024 | $8.38M | +10.2% |
| Q2 FY2024 | Jun 30, 2024 | $10.44M | +13.0% |
| Q1 FY2024 | Mar 31, 2024 | $5.06M | -24.0% |
| Q4 FY2023 | Dec 31, 2023 | $6.75M | -27.2% |
| Q3 FY2023 | Sep 30, 2023 | $7.60M | -38.4% |
| Q2 FY2023 | Jun 30, 2023 | $9.24M | -39.6% |
| Q1 FY2023 | Mar 31, 2023 | $6.65M | -39.2% |
| Q4 FY2022 | Dec 31, 2022 | $9.27M | -28.0% |
| Q3 FY2022 | Sep 30, 2022 | $12.34M | -19.4% |
| Q2 FY2022 | Jun 30, 2022 | $15.31M | -11.2% |
| Q1 FY2022 | Mar 31, 2022 | $10.94M | -42.1% |
| Q4 FY2021 | Dec 31, 2021 | $12.87M | +46.9% |
| Q3 FY2021 | Sep 30, 2021 | $15.31M | +185.6% |
| Q2 FY2021 | Jun 30, 2021 | $17.24M | +502.3% |
| Q1 FY2021 | Mar 31, 2021 | $18.90M | +329.6% |
| Q4 FY2020 | Dec 31, 2020 | $8.76M | +22.1% |
| Q3 FY2020 | Sep 30, 2020 | $5.36M | +48.3% |
| Q2 FY2020 | Jun 30, 2020 | $2.86M | -10.3% |
| Q1 FY2020 | Mar 31, 2020 | $4.40M | -5.1% |
| Q4 FY2019 | Dec 31, 2019 | $7.18M | -0.6% |
| Q3 FY2019 | Sep 30, 2019 | $3.62M | +179.9% |
| Q2 FY2019 | Jun 30, 2019 | $3.19M | +4.8% |
| Q1 FY2019 | Mar 31, 2019 | $4.64M | +25.7% |
| Q4 FY2018 | Dec 31, 2018 | $7.22M | +17.9% |
| Q3 FY2018 | Sep 30, 2018 | $1.29M | -82.7% |
| Q2 FY2018 | Jun 30, 2018 | $3.05M | -61.7% |
| Q1 FY2018 | Mar 31, 2018 | $3.69M | +576.9% |
| Q4 FY2017 | Dec 31, 2017 | $6.12M | +1147.8% |
| Q3 FY2017 | Sep 30, 2017 | $7.48M | – |
| Q2 FY2017 | Jun 30, 2017 | $7.94M | – |
| Q1 FY2017 | Mar 31, 2017 | $545.13K | – |
| Q4 FY2016 | Dec 31, 2016 | $490.76K | – |
See a number that looks wrong?